We specialize in accelerating investigator-initiated clinical trials. If you have an idea for a lung cancer trial, we can provide:
- Funding
- Trial Design Support
- Operational Staff
- Reporting Assistance
- Specimen Collection and Storage
- Access to our biospecimen bank
- And more
Consortium Benefits
By joining the ALCMI research consortium, lung cancer researchers and academic medical institutions can enjoy a host of benefits that can significantly enhance their research endeavors:
- Collaborative Network. ALCMI brings together a world-class team of lung cancer scientists and clinicians from prestigious institutions globally. This network fosters collaboration and accelerates research progress.
- Rapid Clinical Trial Launch. The consortium’s Master Collaboration Agreement enables rapid initiation of clinical trials, whether center-based or through decentralized methods. This flexibility allows for efficient and timely research.
- Robust Operational Platforms. ALCMI provides operational support, including centralized tissue banks and data systems. This infrastructure streamlines research processes and enhances data quality.
- Innovative Research Projects. The consortium drives cutting-edge research initiatives, such as explorations into why young people are developing young cancer, how lung cancer can run in families, and understanding resistance mechanisms in current treatments.
- Regulatory Compliance. All ALCMI trials adhere to International Conference of Harmonization (ICH) standards, Good Clinical Practice (GCP) best practices, and U.S. Food and Drug Administration (FDA) regulations. This ensures high-quality and reliable research outcomes.
- Global Impact. By joining ALCMI, researchers and institutions contribute to a global effort to advance lung cancer research and improve patient outcomes. The consortium’s collaborative approach amplifies the impact of individual research efforts.
Why Join ALCMI
Joining ALCMI means being part of a dynamic and innovative community dedicated to making significant strides in lung cancer research. It’s an opportunity to collaborate, innovate, and make a real difference in the fight against lung cancer.
We want to work with the most innovative minds in lung cancer research.
If you'd like to work together, we'd love to hear from you.
Our approach to collaboration is flexible. We have experience working under a variety of agreements and contracts, and we're open to finding a solution that works for both parties.
In many cases, we establish Master Collaboration Agreements with research facilities and institutions, which allows us to get clinical trials up and running quickly. We also have other methods to speed up the process when those agreements aren't already in place.
In the end, we want to help you get your clinical trial idea off the ground.
Let's cure lung cancer together!
Would you like more information on any specific aspect of the consortium? Contact us, and let's start the conversation.
